KYTHERA Biopharmaceuticals (KYTH) IPO Indicated to Open
- Procter & Gamble (PG) Reports In-Line Q1 EPS; To Spin-Off Duracell
- Dallas Ebola Nurse Nina Pham now cured - NIH Says
- Ford Motor (F) Tops Q3 EPS by 5c
- SodaStream (SODA) Confirms 'Small-Scale' PepsiCo (PEP) Test
The IPO for KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) is expected to open at 10:20AM ET after pricing 4,400,000 shares at $16, the top end of the expected $14-$16 range.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program
- Mutual-to-Stock IPO for Melrose Bancorp Opens Up 30%
- Shell Midstream Partners, L.P. (SHLX) Launches 37.5M Common IPO